DRI Healthcare Trust (TSE:DHT.UN) Shares Down 1% – Time to Sell?

DRI Healthcare Trust (TSE:DHT.UN – Get Free Report)’s share price was down 1% on Wednesday. The company traded as low as C$17.92 and last traded at C$17.98. Approximately 18,844 shares were traded during trading, a decline of 66% from the average daily volume of 55,433 shares. The stock had previously closed at C$18.17.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on DHT.UN. Stifel Nicolaus upped their price objective on shares of DRI Healthcare Trust from C$25.00 to C$26.00 and gave the stock a “buy” rating in a report on Tuesday, August 11th. National Bank Financial raised their target price on DRI Healthcare Trust from C$23.50 to C$25.50 and gave the company an “outperform” rating in a report on Tuesday, September 22nd. Canaccord Genuity Group raised their target price on DRI Healthcare Trust from C$22.25 to C$23.00 and gave the company a “buy” rating in a report on Tuesday, June 30th. Finally, Raymond James Financial boosted their price target on DRI Healthcare Trust from C$22.50 to C$23.50 and gave the stock a “strong-buy” rating in a research report on Monday, June 29th. One research analyst has rated the stock with a Strong Buy rating and four have issued a Buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of C$25.60.

Check Out Our Latest Research Report on DRI Healthcare Trust

DRI Healthcare Trust Price Performance

The firm has a fifty day simple moving average of C$17.84 and a 200 day simple moving average of C$17.51. The company has a market cap of C$982.74 million, a price-to-earnings ratio of -22.35 and a beta of 0.10.

DRI Healthcare Trust Company Profile

(Get Free Report)

DRI Healthcare is a pioneer in global pharmaceutical royalty monetization. Since our founding in 1989, we have deployed more than $3 billion, acquiring more than 75 royalties on 50-plus drugs, including Eylea, Keytruda, Lumvoa, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. DRI Healthcare’s units are listed and trade on the TSX in Canadian dollars under the symbol ‘DHT.UN’ and in U.S. dollars under the symbol ‘DHT.U’. To learn more, visit drihealthcare.com or follow us on LinkedIn.

See Also

Receive News & Ratings for DRI Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DRI Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.